date,title,body,url,image,source
2021-10-26T07:00:00+00:00,"DERMALA, A Consumer Dermatology Company, Announces Issuance of the Second U.S. Patent Covering the Use of Novel Human Microbiome Technology for Treating Acne Vulgaris","SAN DIEGO, Oct. 26, 2021 /PRNewswire/ -- DERMALA, a consumer dermatology company developing novel, personalized, microbiome-powered solutions for chronic skin conditions, announced today the ...",https://markets.businessinsider.com/news/stocks/dermala-a-consumer-dermatology-company-announces-issuance-of-the-second-u-s-patent-covering-the-use-of-novel-human-microbiome-technology-for-treating-acne-vulgaris-1030899083,,Business Insider
2020-11-09T08:01:00+00:00,DERMALA Announces $6.73 Million Series A Financing to Expand and Scale Company's Personalized Microbiome-Based Solutions for Acne and Other Skin Conditions,"SAN DIEGO--(BUSINESS WIRE)--DERMALA, Inc., a consumer dermatology company developing novel, personalized, microbiome-based solutions for acne and other skin conditions, announced today that it has ...",https://www.businesswire.com/news/home/20201109005312/en/DERMALA-Announces-6.73-Million-Series-A-Financing-to-Expand-and-Scale-Companyâ€™s-Personalized-Microbiome-Based-Solutions-for-Acne-and-Other-Skin-Conditions,,Business Wire
